Cosmo Pharmaceuticals (OTCMKTS:CMOPF) Sees Significant Increase in Short Interest

Cosmo Pharmaceuticals (OTCMKTS:CMOPF) saw a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 34,276 shares, a growth of 64.9% from the September 30th total of 20,782 shares. Based on an average daily volume of 1,281 shares, the short-interest ratio is presently 26.8 days.

Cosmo Pharmaceuticals Stock Performance

OTCMKTS:CMOPF opened at C$68.20 on Monday. Cosmo Pharmaceuticals has a fifty-two week low of C$59.02 and a fifty-two week high of C$169.90. The company’s 50-day simple moving average is C$66.78 and its 200-day simple moving average is C$97.44.

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. is an international pharmaceutical company focused on developing, manufacturing and commercializing treatments for gastrointestinal and dermatological conditions. The company uses its proprietary MMX drug-delivery technology to formulate therapies designed to release active ingredients at targeted locations in the gastrointestinal tract.

Cosmo’s gastrointestinal portfolio includes products for inflammatory bowel disease and other digestive disorders, including mesalamine-based therapies and rifamycin-based treatments.